https://www.mithra.com/wp-content/uploads/2019/02/mgmt-team.jpg 1310 1920 Mithra Pharmaceuticals https://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.png Mithra Pharmaceuticals2019-07-16 07:30:202019-07-15 17:59:55Mithra CDMO Strengthens its Management Team and Accelerates Key R&D Programs
- Strengthening of management team with key appointments of Chief Scientific Officer and Plant Manager, to support the strategy execution of Mithra CDMO
- Consolidation of R&D and manufacturing teams with 30% increase in highly qualified staff since the beginning of the year
- Donesta® and PeriNesta® Phase III studies ready to begin, pending approval by authorities
- Launch of production of Estelle® clinical validation batches for both U.S. and EU filing
- Positive outcome of the registration procedure for Myring™, adding 15 new Market Authorizations in Europe
Liege, Belgium, 16 July 2019 – 7 :30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, announces it has strengthened its CDMO Management team with the appointments of Dr Graham Dixon as Chief Scientific Officer and Mr Renaat Baes as Plant Manager.